首页 | 本学科首页   官方微博 | 高级检索  
检索        

骨形态发生蛋白2基因治疗与缓释载体修复骨缺损的比较研究
引用本文:李建军,傅永慧,孙鸿斌,韩冬,王海义,徐莘香.骨形态发生蛋白2基因治疗与缓释载体修复骨缺损的比较研究[J].中国矫形外科杂志,2005,13(17):1334-1336.
作者姓名:李建军  傅永慧  孙鸿斌  韩冬  王海义  徐莘香
作者单位:1. 中国医科大学附属二院骨科,沈阳,110003
2. 吉林大学中日联谊医院手外科
3. 锦州医学院附属一院骨科
4. 吉林大学第一医院骨科
基金项目:国家自然科学基金课题(No.39800151);吉林省科技发展计划(N0.20010110)
摘    要:目的]比较骨形态发生蛋白2(BMP-2)基因治疗与生长因子缓释方法修复节段性骨缺损效果。方法]于兔双侧桡骨中段造成1.5cm骨缺损,采用4种方法修复:A组植入转基因骨髓间质干细胞(MSCs)与PLA/PCL(聚乳酸/聚己内酯)支架的复合物;B组植入单纯MSCs与含重组BMP-2的PLA/PCL缓释载体的复合物;C组植入单纯MSCs与PLA/PCL复合物;D组植入单纯PLA/PCL。术后4、8、12周行X线、组织学、生物力学和骨密度等检测,结果]A组体内植入4周后,成骨细胞和间质细胞呈BMP-2强阳性表达;其成骨速度及成骨质量均明显优于B组,12周时骨缺损完全修复、C组成骨能力较弱,而D组则无新骨形成,残留骨缺损。结论]BMP-2基因治疗是修复节段性骨缺损的好方法。

关 键 词:骨形态发生蛋自  基因治疗  缓释  骨髓间充质干细胞  骨形态发生蛋白2  节段性骨缺损  缓释载体  修复  骨髓间质干细胞  体内植入
收稿时间:2005-03-02
修稿时间:2005-05-30

Comparison between gene therapy and gradual release carrier for bone morphogenetic protein-2 in repairing bone defects
Li JianJun;Fu YongHui;Sun HongBin;Han Dong;Wang HaiYi;Xu ShenXiang.Comparison between gene therapy and gradual release carrier for bone morphogenetic protein-2 in repairing bone defects[J].The Orthopedic Journal of China,2005,13(17):1334-1336.
Authors:Li JianJun;Fu YongHui;Sun HongBin;Han Dong;Wang HaiYi;Xu ShenXiang
Abstract:Objective]To compare the effects between gene therapy and gradual release carrier for bone morphogenetic protein-2(BMP-2)in repairing bone defects.Method]Bone defects of 15 mm were created on the bilateral radius in rabbits and treated with four kinds of implantations,ie,composition of transgeneie MSCs and PLA/PCL(Group A),composition of MSCs and gradual release carrier for BMP-2(Group B),composition of MSCs and PLA/PCL(Group C),and PLA/PCL alone(Group D).After 4,8,and 12 weeks from the operations,X-ray,histological examination,biomechanics analysis,and bone density measurement were conducted.Result]After 4 weeks from the operations,in Group A both osteoblasts and mesenchymal cells displayed strongly positive expression of BMP-2;the speed and quality of bone formation in Group A were much better than those in Group B.After 12 weeks form the operations,bone defects were completely repaired in Group A.Conclusion]BMP-2 gene therapy is really a good method to repair segmental bone defects.
Keywords:Bone morphogenetic proteins  Gene therapy  Gradual release  Mesenchymal stem cells
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号